NCT02489734

Brief Summary

The purpose of this study is to determine whether the incidence of emergence delirium will be reduced when end-tidal concentration of sevoflurane decreases.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
109

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2015

Shorter than P25 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 16, 2015

Completed
15 days until next milestone

Study Start

First participant enrolled

July 1, 2015

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 3, 2015

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2015

Completed
6 years until next milestone

Results Posted

Study results publicly available

August 19, 2021

Completed
Last Updated

August 19, 2021

Status Verified

August 1, 2020

Enrollment Period

2 months

First QC Date

June 16, 2015

Results QC Date

August 19, 2020

Last Update Submit

July 27, 2021

Conditions

Keywords

sevofluraneemergence deliriumpreschool

Outcome Measures

Primary Outcomes (1)

  • Number of Participants With Emergence Delirium (ED)

    The primary outcome was the number of participants with emergence delirium (ED) according to the peak PAED score measured by Pediatric Anesthesia Emergence Delirium Scale. All PAED (Pediatric Anesthesia Emergence Delirium scale) scores were assessed by a dedicated nurse who was blinded to the random assignment of patients to group. PAED scores were assessed on awakening (defined as reactive to verbal command or opening of eyes or crying in response to slight touch) and then every 5 minutes for 30 minutes. If the PAED score was ≥ 16, propofol 1 mg.kg-1 was administrated. After administration of propofol, PAED scores were no longer assessed. The peak (highest) PAED score for each patient was analyzed. ED was defined as a peak PAED score \>12. Higher score of PAED means a worse outcome.

    within 30 minutes after awakening

Study Arms (2)

low concentration (LC)

EXPERIMENTAL

low concentration group

Drug: sevoflurane

high concentration (HC)

EXPERIMENTAL

high concentration group

Drug: Sevoflurane

Interventions

extubation when end-tidal concentration of sevoflurane \< 0.5%

low concentration (LC)

Eligibility Criteria

Age2 Years - 7 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Age 2-7 years
  • ASA I - II
  • Estimated surgery time \< 2 hours
  • Sevoflurane induction and maintenance along with caudal block or Axillary Block

You may not qualify if:

  • Craniofacial anomalies
  • Difficult exposure of the vocal cordS
  • Obesity
  • Asthma
  • Invalid caudal block or axillary block

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Emergence Delirium

Interventions

Sevoflurane

Condition Hierarchy (Ancestors)

DeliriumConfusionNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and SymptomsNeurocognitive DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Methyl EthersEthersOrganic ChemicalsHydrocarbons, FluorinatedHydrocarbons, HalogenatedHydrocarbons

Limitations and Caveats

First, the patients might have experienced pain in the PACU. However, distinguishing ED from pain in the PACU could be difficult. Second, we did not observe the duration of each case of ED.

Results Point of Contact

Title
Dr. Xuan Wang
Organization
Children's Hospital of Fudan University

Study Officials

  • Xuan Wang

    Children's Hospital of Fudan University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 16, 2015

First Posted

July 3, 2015

Study Start

July 1, 2015

Primary Completion

September 1, 2015

Study Completion

September 1, 2015

Last Updated

August 19, 2021

Results First Posted

August 19, 2021

Record last verified: 2020-08